Search Results - "Vedin, Inger"

Refine Results
  1. 1
  2. 2

    DHA-rich n–3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study by Karimi, Mohsen, Vedin, Inger, Freund Levi, Yvonne, Basun, Hans, Faxén Irving, Gerd, Eriksdotter, Maria, Wahlund, Lars-Olof, Schultzberg, Marianne, Hjorth, Erik, Cederholm, Tommy, Palmblad, Jan

    Published in The American journal of clinical nutrition (01-10-2017)
    “…Abstract Background: Dietary fish oils, rich in long-chain n–3 (ω-3) fatty acids (FAs) [e.g., docosahexaenoic acid (DHA, 22:6n–3) and eicosapentaenoic acid…”
    Get full text
    Journal Article
  3. 3

    Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study[S] by Wang, Xiuzhe, Hjorth, Erik, Vedin, Inger, Eriksdotter, Maria, Freund-Levi, Yvonne, Wahlund, Lars-Olof, Cederholm, Tommy, Palmblad, Jan, Schultzberg, Marianne

    Published in Journal of lipid research (01-03-2015)
    “…Specialized proresolving mediators (SPMs) induce resolution of inflammation. SPMs are derivatives of n-3 and n-6 PUFAs and may mediate their beneficial…”
    Get full text
    Journal Article
  4. 4

    Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study by Vedin, Inger, Cederholm, Tommy, Freund-Levi, Yvonne, Basun, Hans, Garlind, Anita, Irving, Gerd Faxén, Eriksdotter-Jönhagen, Maria, Wahlund, Lars-Olof, Dahlman, Ingrid, Palmblad, Jan

    Published in PloS one (24-04-2012)
    “…Dietary fish oil, rich in n-3 fatty acids (n-3 FAs), e.g. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), regulate inflammatory reactions by…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms by Freund-Levi, Yvonne, Basun, Hans, Cederholm, Tommy, Faxén-Irving, Gerd, Garlind, Anita, Grut, Mikaela, Vedin, Inger, Palmblad, Jan, Wahlund, Lars-Olof, Eriksdotter-Jönhagen, Maria

    “…Background Epidemiological and animal studies have suggested that dietary fish or fish oil rich in omega‐3 fatty acids (ω3), docosahexaenoic acid (DHA) and…”
    Get full text
    Journal Article
  7. 7

    Reduced prostaglandin F2α release from blood mononuclear leukocytes after oral supplementation of ω3 fatty acids: the OmegAD study by Vedin, Inger, Cederholm, Tommy, Freund-Levi, Yvonne, Basun, Hans, Hjorth, Erik, Irving, Gerd Faxén, Eriksdotter-Jönhagen, Maria, Schultzberg, Marianne, Wahlund, Lars-Olof, Palmblad, Jan

    Published in Journal of lipid research (01-05-2010)
    “…Omega-3 fatty acids, e.g., dokosahexaenoic acid (DHA) and eikosapentaenoic acid (EPA), ameliorate inflammatory reactions by various mechanisms, but the role of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts by Nikpour, M, Scharenberg, C, Liu, A, Conte, S, Karimi, M, Mortera-Blanco, T, Giai, V, Fernandez-Mercado, M, Papaemmanuil, E, Högstrand, K, Jansson, M, Vedin, I, Stephen Wainscoat, J, Campbell, P, Cazzola, M, Boultwood, J, Grandien, A, Hellström-Lindberg, E

    Published in Leukemia (01-04-2013)
    “…Refractory anemia with ring sideroblasts (RARS) is characterized by mitochondrial ferritin (FTMT) accumulation and markedly suppressed expression of the iron…”
    Get full text
    Journal Article
  11. 11

    DHA-rich n–3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study123 by Karimi, Mohsen, Vedin, Inger, Freund Levi, Yvonne, Basun, Hans, Faxén Irving, Gerd, Eriksdotter, Maria, Wahlund, Lars-Olof, Schultzberg, Marianne, Hjorth, Erik, Cederholm, Tommy, Palmblad, Jan

    Published in The American journal of clinical nutrition (01-04-2017)
    “…Dietary fish oils, rich in long-chain n–3 (ω-3) fatty acids (FAs) [e.g., docosahexaenoic acid (DHA, 22:6n–3) and eicosapentaenoic acid (EPA, 20:5n–3)],…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab by Ajeganova, Sofia, Tesfa, Daniel, Hägglund, Hans, Fadeel, Bengt, Vedin, Inger, Zignego, Anna Linda, Palmblad, Jan

    Published in Arthritis research & therapy (07-03-2017)
    “…The causes and mechanisms of late-onset neutropenia (LON) following rituximab treatment in patients with rheumatic diseases are not known. In this study, we…”
    Get full text
    Journal Article
  14. 14

    Low pericyte coverage of endometrial microvessels in heavy menstrual bleeding correlates with the microvessel expression of VEGF-A by ANDERSSON, EMIL, ZETTERBERG, EVA, VEDIN, INGER, HULTENBY, KJELL, PALMBLAD, JAN, MINTS, MIRIAM

    “…A prospective clinical study was carried out to investigate whether endometrial microvessels in patients with idiopathic heavy menstrual bleeding (HMB) of…”
    Get full text
    Journal Article
  15. 15

    X‐linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: Comparisons with primary myelofibrosis by Åström, Maria, Hahn‐Strömberg, Victoria, Zetterberg, Eva, Vedin, Inger, Merup, Mats, Palmblad, Jan

    Published in American journal of hematology (01-03-2015)
    “…X‐linked thrombocytopenia with thalassemia (XLTT) is caused by the mutation 216R > Q in exon 4 of the GATA1 gene. Male hemizygous patients display…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20